EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PSD95 as a New Potential Therapeutic Target of Osteoarthritis: A Study of the Identification of Hub Genes through Self-Contrast Model

Ping Huang, Jieming Lin, Hongxing Shen, Xiang Zhao

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ping Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Cartilage, Articular, Cartilage Diseases. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Commission of Health and Family Planning, Shanghai Municipal Health Commission of Family Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a worldwide joint disease. However, the precise mechanism causing OA remains unclear. Our primary aim was to identify vital biomarkers associated with the mechano-inflammatory aspect of OA, providing potential diagnostic and therapeutic targets for OA. Thirty OA patients who underwent total knee arthroplasty were recruited, and cartilage samples were obtained from both the lateral tibial plateau (LTP) and medial tibial plateau (MTP). GO and KEGG enrichment analyses were performed, and the protein–protein interaction (PPI) assessment was conducted for hub genes. The effect of PSD95 inhibition on cartilage degeneration was also conducted and analyzed. A total of 1247 upregulated and 244 downregulated DEGs were identified. Significant differences were observed between MTP and LTP in mechanical stress-related genes and activated sensory neurons based on a self-contrast model of human knee OA. Cluster analysis identified DLG4 as the hub gene. Cyclic loading stress increased PSD95 (encoded by DLG4) expression in LTP cartilage, and PSD95 inhibitors could alleviate OA progression. This study suggests that inhibiting PSD95 could be a potential therapeutic strategy for preventing articular cartilage degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthritis, KneeCartilage, ArticularCartilage DiseasesHumansKnee JointTibiaTranscription Factors

Stichwörter der Autor:innen

DLG4PSD95RNA sequencinghub geneosteoarthritis

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Department of Orthopaedics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Department of Spine Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Förderung

  • Shanghai Municipal Commission of Health and Family Planning
  • Shanghai Municipal Health Commission of Family Planning

Zitieren

APA

Huang, P., Lin, J., Shen, H., & Zhao, X. (2023). PSD95 as a New Potential Therapeutic Target of Osteoarthritis: A Study of the Identification of Hub Genes through Self-Contrast Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914682

Vancouver

Huang P, Lin J, Shen H, Zhao X. PSD95 as a New Potential Therapeutic Target of Osteoarthritis: A Study of the Identification of Hub Genes through Self-Contrast Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914682

BibTeX
@article{Huang2023,
  author = {Huang, Ping and Lin, Jieming and Shen, Hongxing and Zhao, Xiang},
  title = {PSD95 as a New Potential Therapeutic Target of Osteoarthritis: A Study of the Identification of Hub Genes through Self-Contrast Model},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914682}
}
Kostenlos starten →